Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Invitrogen™ TNFAIP8L1 Polyclonal Antibody
Rabbit Polyclonal Antibody
Supplier: Invitrogen™ PA569889
Description
This target displays homology in the following species: Cow: 93%; Dog: 100%; Horse: 100%; Human: 100%; Mouse: 93%; Rat: 100%.
Tumor necrosis factor, α-induced protein 8-like 1, also known as TNFα-IP 8L1, is a 186 amino acid protein belonging to the TNFα-IP 8 family. Members of the TNFα-IP 8 family are induced by nuclear factor-κB 9 (NFκB) and tumor necrosis factor (TNF), although induction by TNF is dependent upon NFκB activation. TNFα-IP 8 proteins also act as a negative mediator of apoptosis and may play a role in tumor progression. They suppress TNF-mediated apoptosis by inhibiting caspase-8 activity but not the processing of procaspase-8, subsequently resulting in inhibition of BID cleavage and caspase-3 activation.
Specifications
TNFAIP8L1 | |
Polyclonal | |
Unconjugated | |
TNFAIP8L1 | |
2600017J23Rik; Oxidative stress regulated gene-beta; oxidative stress-regulated gene-beta; Oxy-beta; TIPE1; TNF alpha induced protein 8 like 1; TNF alpha-induced protein 8-like protein 1; Tnfaip8l1; TNFAIP8-like protein 1; Tumor necrosis factor alpha-induced protein 8-like protein 1; tumor necrosis factor, alpha induced protein 8 like 1; tumor necrosis factor, alpha-induced protein 8-like 1; tumor necrosis factor, alpha-induced protein 8-like protein 1 | |
Rabbit | |
Affinity chromatography | |
RUO | |
126282 | |
-20°C, Avoid Freeze/Thaw Cycles | |
Liquid |
Western Blot | |
0.5 mg/mL | |
PBS with 2% sucrose and 0.09% sodium azide | |
Q8WVP5 | |
TNFAIP8L1 | |
synthetic peptide directed towards the middle region of human TNFAIP8L1. | |
100 μL | |
Primary | |
Human | |
Antibody | |
IgG |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction